Acarix, a leader acoustic and AI-based cardiac diagnostics announces that the company will present at the 7th Annual Nordic American Life Science Conference, the most comprehensive Nordic life science innovation gathering in the United States.
Taking place in New York City, December 7-8, 2022, the Nordic American Life Science Conference brings together investors, corporate development executives and industry partners to meet and learn about the most promising Nordic life science companies and investments.
“We are honored that Acarix has been selected as one of the most promising Nordic life science companies to be presented at this event. I am looking forward to providing an update on the company and the important transformation that we are embarking on, as well as taking part in discussions on how our acoustic AI-powered CADScor®System can help improve the assessment for the many millions of patients seeking medical care for stable chest pain in the US”, says Helen Ljungdahl Round.
During the conference, Helen Ljungdahl Round, President & CEO of Acarix, will give a presentation and participate in the panel discussion Nordic Healthtech: an emerging engine of innovation.
Read more about the Annual Nordic American Life Science Conference here:
www.nordic-americanlifescience.com.
